Photo of Whitt Steineker

As co-chair of Bradley’s Cannabis Industry team, Whitt represents clients in a wide range of cannabis issues. In addition to providing a full suite of legal services to cannabis companies, Whitt and the Cannabis Industry team advise non-cannabis clients – from banks to commercial real estate companies to insurance companies and high net worth individuals – on best practices for interacting with cannabis companies.

Whitt is one of the leading voices in the cannabis bar – recognized as a “Go-To Thought Leader” by the National Law Review. He has presented on cannabis issues at conferences around the country.  His work has been featured in the National Law JournalLaw360, and the Westlaw Journal. And he has been quoted in an array of legal and mainstream publications from Law360 and Super Lawyers to the Atlanta Journal-Constitution and the Associated Press.

Only three months – 90(ish) days – until the Alabama Medical Cannabis Commission is scheduled to begin accepting applications for licenses. It was a year ago when this all started. And like raising children, the days pass slowly while the months fly by.

Your perspective depends on where you sit. For many, it feels like

On May 4, 2022, South Carolina’s medical marijuana bill — SB 150, also known as the South Carolina Compassionate Care Act — was ruled unconstitutional by the state’s House of Representatives.

The constitutional challenge was mounted by Rep. John McCravy, who argued that because the bill involves the creation of a new tax, specifically on

When you start a Cannabis Industry team at a law firm based in the Southeastern United States, you get a sense of what Noah must have felt like when he was telling people it was about to rain.

But it did start to rain. And it hasn’t stopped. The Budding Trends blog is a glimpse

What promises to be the first of a litany of legal interpretations of the new Mississippi Medical Cannabis Act (MMCA), Attorney General Lynn Fitch released an official attorney general’s opinion on April 15, 2022, regarding the scope of a municipality’s ability to locally regulate medical cannabis establishment operations through zoning or ordinances. Fitch, applying a

The stratospheric rise of products containing ∆8-tetrahydrocannabinol (Delta-8 THC) and ∆10-tetrahydrocannabinol (Delta-10 THC), both of which can cause psychoactive effects similar to ∆9-THC (the substance codified as “marihuana” by the federal Controlled Substances Act), have raised questions regarding these products’ legality under federal and state law. Recent litigation developments have indicated a possible trend toward

Cannabis operators (from marijuana to hemp-derived products such as CBD) often get the sense they are one of the central targets of the federal government’s reach. But they are not in the same league lately as the COVID-19 virus. Earlier this month, those worlds collided.

The U.S. Food and Drug Administration (FDA) and the Federal

The Mississippi Department of Revenue (MDOR) released information on Friday, April 15, regarding the licensing and operations of dispensaries under the medical cannabis regime in Mississippi. We feel like a broken record, but as more and more information is revealed, it becomes more and more evident that entities wanting to obtain a license as soon as

Given the explosive growth of cannabis products and the increasing number of states that have legalized marijuana for medicinal or adult use (nearly 40 at last count), employers across the country are asking whether they can terminate an employee for a positive drug test for marijuana. What if the test shows marijuana metabolites but you